Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BI 765845 in Healthy Japanese Males
NCT06139341Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial in acute myocardial infarction (AMI) comparing BI 765845 with Placebo (2 arms). Primary endpoint: Percentage of subjects with treatment-emergent adverse event assessed as drug-related up to 73 days. Started Jul 2023; status: completed.
02
Drugs
BI 765845
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT06139341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06139341.